Literature DB >> 34956509

Analysis of pathogens, drug resistance, sensitive antibiotic treatment and risk factors of early-onset sepsis in very low birth weight infants.

Yingying Yu1, Qikun Huang2, Anchang Liu1.   

Abstract

The clinical manifestations, types of infectious pathogens, and drug-resistant strains of sepsis in infants with very low birth weight (VLBWIs) vary greatly in different regions and hospitals. In order to improve the level of diagnosis and treatment, this study analyzed the distribution and drug resistance of the pathogenic bacteria of sepsis in VLBWIs in our hospital. A total of 69 cases of VLBWIs in Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University from January 01, 2014 to December 31, 2020 were included. Among them, 34 VLBWIs with early-onset sepsis (EOS) were assigned to the EOS group, and 14 VLBWIs with late-onset sepsis (LOS) were included in the LOS group. The distribution of pathogens and the drug resistance of antibiotics were analyzed. The results showed that fluorescent nanoparticles detected pathogenic bacteria in 48 cases, and the blood cultures were all positive. A total of 49 pathogenic bacteria were isolated, including 27 gram-negative bacteria (55.1%), 21 gram-positive bacteria (42.86%), and 1 fungus (2.04%, Candida albicans). Gram-negative bacteria comprised of E.coli and Klebsiella pneumoniae, which were highly sensitive to compound preparations containing β-lactamase inhibitors, and carbapenem antibacterial drugs, were the first choice. Gram-positive bacteria were mainly Staphylococcus epidermidis and Streptococcus agalactiae. Staphylococcus epidermidis was highly resistant to penicillins and can be treated with vancomycin. Streptococcus agalactiae was highly resistant to penicillins and can be treated with penicillin and vancomycin. Amniotic fluid pollution, intrauterine distress, premature rupture of membranes, and maternal fever were risk factors for EOS in VLBWIs, with odds ratios (ORs) of 9.369, 6.217, 5.638, and 4.267, respectively. In summary, timely and reasonable treatment should be given based on the types and drug resistance characteristics of pathogens of neonatal sepsis and the risk factors of EOS. AJTR
Copyright © 2021.

Entities:  

Keywords:  Very low birth weight infants; antibiotics; drug resistance; early-onset sepsis; pathogens; risk factors

Year:  2021        PMID: 34956509      PMCID: PMC8661145     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  32 in total

Review 1.  Aptamers coupled to nanoparticles in the diagnosis and treatment of microbial infections.

Authors:  Juan Carlos Gutiérrez-Santana; Julia Dolores Toscano-Garibay; Marisol López-López; Victor Rafael Coria-Jiménez
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2020-01-13

Review 2.  Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Authors:  Sagori Mukhopadhyay; Kelly C Wade; Karen M Puopolo
Journal:  Clin Perinatol       Date:  2019-03-30       Impact factor: 3.430

Review 3.  Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Authors:  Karen M Puopolo; William E Benitz; Theoklis E Zaoutis
Journal:  Pediatrics       Date:  2018-12       Impact factor: 7.124

Review 4.  Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF).

Authors:  Loïc Sentilhes; Christophe Vayssière; Gael Beucher; Catherine Deneux-Tharaux; Philippe Deruelle; Pierre Diemunsch; Denis Gallot; Jean-Baptiste Haumonté; Sonia Heimann; Gilles Kayem; Emmanuel Lopez; Olivier Parant; Thomas Schmitz; Yann Sellier; Patrick Rozenberg; Claude d'Ercole
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-06-28       Impact factor: 2.435

5.  Magneto-Fluorescent Microbeads for Bacteria Detection Constructed from Superparamagnetic Fe3O4 Nanoparticles and AIS/ZnS Quantum Dots.

Authors:  Irina V Martynenko; Dragana Kusić; Florian Weigert; Shelley Stafford; Fearghal C Donnelly; Roman Evstigneev; Yulia Gromova; Alexander V Baranov; Bastian Rühle; Hans-Jörg Kunte; Yurii K Gun'ko; Ute Resch-Genger
Journal:  Anal Chem       Date:  2019-09-30       Impact factor: 6.986

6.  Antibiotic regimens for late-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Gorm Greisen; Munish Gupta; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-08

7.  Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal Network.

Authors:  Christoph Härtel; Kirstin Faust; Stefan Avenarius; Bettina Bohnhorst; Michael Emeis; Corinna Gebauer; Peter Groneck; Friedhelm Heitmann; Thomas Hoehn; Mechthild Hubert; Angela Kribs; Helmut Küster; Reinhard Laux; Michael Mögel; Dirk Müller; Dirk Olbertz; Claudia Roll; Jens Siegel; Anja Stein; Matthias Vochem; Ursula Weller; Axel von der Wense; Christian Wieg; Jürgen Wintgens; Claudia Hemmelmann; Arne Simon; Egbert Herting; Wolfgang Göpel
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Risk Factors for Neonatal Sepsis in Pregnant Women with Premature Rupture of the Membrane.

Authors:  Dwiana Ocviyanti; William Timotius Wahono
Journal:  J Pregnancy       Date:  2018-10-01

9.  Risk factors of neonatal sepsis in India: A systematic review and meta-analysis.

Authors:  Shruti Murthy; Myron Anthony Godinho; Vasudeva Guddattu; Leslie Edward Simon Lewis; N Sreekumaran Nair
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

10.  Simultaneous Sensing of Seven Pathogenic Bacteria by Guanidine-Functionalized Upconversion Fluorescent Nanoparticles.

Authors:  Mingyuan Yin; Chen Wu; Haijie Li; Zhixin Jia; Qiliang Deng; Shuo Wang; Yukui Zhang
Journal:  ACS Omega       Date:  2019-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.